It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for ProQR Therapeutics N.V. (PRQR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 3.83%, to $2.98. The ProQR Therapeutics N.V. has recorded 2 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
ProQR Therapeutics N.V. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.87 and fluctuated between $2.9400 as its day high and $2.7850 as its day low. The current market capitalization of ProQR Therapeutics N.V. is $218.35M. A total of 0.84 million shares were traded on the day, compared to an average of 2.92M shares.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for PRQR in the last 3 months, the mean price target is $3.27 with high estimates of $5.00 and low estimates of $0.94. In terms of 52-week highs and lows, PRQR has a high of $3.78 and a low of $0.53.
As of this writing, PRQR has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.2 in the last quarter, which was 4.80% higher than expectations of -$0.21.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRQR is Overweight with a score of 4.00. A total of 3 analysts rated the stock as Buy while 1 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.